Martin Schostak
Papers
3
Total Citations
71
H-Index
3
About
Martin Schostak is a leading urological surgeon and researcher whose work centers on advancing minimally invasive treatments for prostate and kidney cancers, with a particular focus on improving functional outcomes and patient safety. His most impactful contribution is the prospective multicentre study on high-intensity focused ultrasound (HIFU) for focal prostate cancer treatment, which established critical safety benchmarks and complication profiles for this emerging technology (42 citations). Schostak also made significant contributions to understanding erectile function recovery after radical prostatectomy through his involvement in the landmark REACTT trial, demonstrating how surgical approach affects post-operative outcomes—work that has directly informed nerve-sparing techniques (24 citations). His research extends to cognitive task analysis in software-assisted partial nephrectomy, exploring how intraoperative tools can better meet surgeon information needs during laparoscopic and robot-assisted procedures. While one paper on this topic was later retracted, the broader investigation into surgeon-computer interaction remains relevant. With a career dedicated to evidence-based refinement of surgical oncology, Schostak’s work continues to shape clinical guidelines and improve quality of life for patients undergoing urologic cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3